December 4, 2013 | Israeli biomed company CollPlant, which develops various collagen products for the pharmaceutical industry, has announced the signing of a memorandum of understanding with an unnamed US-based company. According to the agreement, CollPlant will receive a total of $6 million for selling the rights to use their collagen production technology for the cosmetics industry.
Related posts
Cloud Data-Securing Startup Raises $30M
February 01, 2023
Electronic Tampon Eliminates Yeast Infections
February 01, 2023
Humans Beat AI At Guessing People’s Ages
February 01, 2023
$10M For Cyber Company That Protects Small Businesses
January 31, 2023
Facebook comments